DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
NORD/EURORDIS-Rare Diseases Europe Joint Statement on COVID-19 and Orphan Drug Legislation
The National Organization for Rare Disorders (NORD) and EURORDIS-Rare Diseases Europe share the global concern that diagnostics, therapeutics and vaccines to address COVID-19 be developed expeditiously. Our organizations represent the 30 million people in the US and 30 million people in the EU living with rare diseases. These individuals are disproportionately at risk if they contract this disease and will be among those who benefit the most when such products are developed and made available.
Notwithstanding our community’s stake in solutions for COVID-19, we do not believe that rare disease incentives that exist under our respective laws, the Orphan Drug Act in the US and the EU Regulation on Orphan Medicinal Products, are appropriate for use in this global pandemic in which hundreds of thousands, if not millions, will be affected. These laws have been highly successful at spurring development of therapeutics for those rare diseases which affect a very small number of people in the population and where there was a lack of investment in research.
+myBinderRelated Content
-
news & eventsTrauma, Quarantine, and Isolation – WebinarThe Sickle Cell Mental Health Initiative...
-
news & eventsCOVID-19 Outcomes Among Individuals With Sickle Cell Disease by IASCNAPA – WebinarLearning Objectives: • Understand how...
-
news & eventsExpert Opinion Hydroxyurea Could Prevent Strokes for People With Sickle Cell Disease in Lieu of Transfusions During ...The COVID-19 pandemic threatens to cause...
-
news & eventsCOVID-19 Vaccine Communication Toolkit for Community-Based OrganizationsThe toolkit is designed to help CBOs edu...
-
news & eventsSickle Cell Meetup on Facebook Live and Zoom – Sickle Cell 101Sickle Cell 101 is hosting an online mee...
-
Community CenterListening to Sickle Cell Patients is Crucial During a CrisisI recently was admitted to the hospital ...
-
videos & visualsYou Should Get a COVID-19 Vaccine – Englishhttps://www.youtube.com/watch?v=eeVB7tTU...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.